Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Time to abandon `best supportive care' as a standard of care for NSCLC?

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Time to abandon `best supportive care' as a standard of care for NSCLC?. Pharmacoecon. Outcomes News 283, 5 (2000). https://doi.org/10.1007/BF03267479

    Download citation

    Keywords

    • Paclitaxel
    • Gemcitabine
    • Vinorelbine
    • Vinblastine
    • Well Supportive Care